Ampreloxetine is being developed to address the root cause of blood pressure instability in multiple system atrophy, aiming ...

Strategic AI applications are helping life sciences teams overcome hidden bias, accelerate data discovery, and improve ...

The FDA will now publish adverse event data from FAERS on a daily basis, marking a major step toward greater transparency in drug development.